Written by Jameson Thorne,

Patients with serious neurological conditions are among the most vulnerable any healthcare team can encounter, and the outcomes of decision-making throughout their treatment balance on the thinnest margins because there’s so much at stake. And with Parkinson’s disease impacting more than a million people nationally, tens of thousands of major turning points in these cases crop up each year. As a result, medical professionals must be prepared to choose the right route forward, especially when that means moving from a medical management approach to one involving direct neurosurgical intervention.

Deep Brain Stimulation (DBS) is one option in this context, and because the conditions it addresses are time-sensitive, there’s an imperative to make the decision on intervention at a moment when the treatment will have the desired impact without the associated downsides outweighing the positives. Patient referrals for DBS treatment hinge on a number of symptoms and must also be made in light of a holistic picture of the individual’s health. Clinical teams currently in the dark about the correct approach need to stick around as we address this issue head-on and establish a framework for appropriate next steps.

Clinical Triggers In Parkinson’s Disease Management

In the first instance, clinicians seeking to determine whether a DBS referral is the right next step must keep the indicator of motor complications that aren’t responding to levodopa dosage and/or frequency changes front and center in mind. While this medication might prove efficacious for a protracted period, it’s still possible for dyskinesia to emerge, or for patients to experience periods of diminished responsiveness, in which case there’s a greater likelihood of additional interventions being required sooner rather than later. The good news is that the 5-2-1 rule for advanced Parkinson’s identification gives clinicians an unambiguous way to choose what to do next, as five doses of levodopa per day, two hours of off time, or one hour of dyskinesia should trigger an immediate evaluation.

Similarly, patients may have an appropriate ongoing response to levodopa that leads to positive outcomes, but suffer side effects that are less than desirable, to the point of being deleterious in other ways. Here, the decision to move on with a DBS referral is even simpler, as outcomes from this treatment will align with an individual’s optimal levodopa response, even if other symptoms remain unaffected. Problems with physical frailty, specifically regarding unsteadiness of gait, along with a marked decline in mental faculties, may not be alleviated, for instance.

Refractory tremor is the notable exception to the levodopa response rule. Many patients experience a persistent, high-amplitude tremor that remains socially or functionally debilitating despite optimal medical therapy. In these cases, DBS of the subthalamic nucleus (STN) or internal globus pallidus (GPi) can offer profound relief even when medication fails to suppress the involuntary movement.

Assessing Essential Tremor And Dystonia Benchmarks

Essential tremor (ET) often follows a different referral trajectory than Parkinson’s disease. Because ET is primarily a monosymptomatic disorder, the referral trigger is usually a self-reported loss of independence in activities of daily living, such as feeding, writing, or grooming. When a patient has failed at least two trials of first-line medications like propranolol or primidone, the conversation should shift toward surgical options.

Dystonia presents a more complex set of variables, particularly regarding the timing of intervention. For many forms of primary dystonia, earlier surgery is associated with superior long-term outcomes in neck and limb mobility compared to delaying intervention until fixed contractures develop. Because the brain’s neuroplasticity plays a role in its adaptation to stimulation, referring patients before their dystonic postures become permanent is vital for functional recovery.

• A documented history of medication non-responsiveness or intolerable side effects
• A clear impact on the patient’s ability to maintain employment or social engagement
• The absence of significant cognitive impairment or untreated psychiatric instability

Comprehensive programs like the center for deep brain stimulation in Denver offer a streamlined intake process that integrates these clinical benchmarks into their initial screening. By utilizing a multidisciplinary team, these centers can quickly determine if the patient’s specific phenotype aligns with the known benefits of STN, GPi, or VIM nucleus stimulation.

The Role Of Neuropsychological Screening In Patient Safety

A successful DBS outcome is defined by more than just the reduction of a tremor. It requires preserving the patient’s cognitive and emotional well-being. This is why neuropsychological testing is a non-negotiable component of the pre-surgical workup. Patients with significant pre-existing dementia or severe, untreated depression are at a higher risk for poor postoperative outcomes and may experience a worsening of their cognitive status following electrode implantation.

Clinicians must look for red flags such as rapid cognitive decline, hallucinations that are not related to medication, or significant executive dysfunction. While mild cognitive impairment is not always an absolute contraindication, it does require a more cautious approach and a different target selection, such as prioritizing the GPi over the STN to minimize cognitive side effects.

Shared decision-making hinges on setting realistic expectations regarding what DBS can and cannot do. It is essential to communicate to the patient and their family that while DBS is transformative for motor symptoms, it is not a cure for the underlying neurodegenerative process. The goal is to “turn back the clock” on motor function, providing a period of improved stability and reduced medication burden.

Insurance Considerations And Collaborative Care Workflows

Navigating the logistical hurdles of a DBS referral requires a clear understanding of the documentation needed for insurance approval. Most payers, including Medicare, require documented evidence that the patient has tried and failed appropriate medical therapies. Clear charting that details the specific “off” time, the frequency of dyskinesia, and the functional limitations caused by the tremor will significantly expedite the prior authorization process.

The relationship between the referring neurologist and the neurosurgical team should be collaborative rather than transactional. A transparent communication loop ensures that the patient’s long-term programming and medication adjustments are managed cohesively. Many high-volume centers give the referring physician detailed intraoperative data and postoperative programming parameters to ensure continuity of care.

Referrals should ideally happen when the patient is still in a relatively stable phase of their disease. Referring too late can mean that the patient has developed “red flag” symptoms like significant dysphagia, frequent falls that are non-responsive to medication, or severe postural instability. These symptoms are rarely improved by DBS and can sometimes be exacerbated by the procedure if not managed carefully.

Implementing A Referral Checklist For Clinical Teams

To ensure no patient misses their window of opportunity, clinical teams should adopt a standardized screening tool. This prevents the “wait and see” approach that often leads to suboptimal outcomes. A quick review of the patient’s medication log and a brief discussion about their quality of life can often reveal hidden motor fluctuations that the patient may have adapted to or failed to report.

When discussing the referral with the patient, emphasize that an evaluation is not a commitment to surgery. It is a consultation to gather data and explore options. Many patients harbor outdated fears about “brain surgery” and may be relieved to learn about the minimally invasive nature of modern stereotactic techniques and the availability of rechargeable or remote programming options.

The inclusion of the family in these discussions is paramount. Since the patient may not always be the best judge of their own “off” periods or cognitive shifts, the observations of a spouse or caregiver give important context for the surgical team. This holistic view ensures that the surgical plan is tailored to the patient’s actual lived experience rather than just their clinical presentation during a brief office visit.

Navigating The Postoperative Integration Period

Once the hardware is implanted, the focus shifts to the programming phase. This is an iterative process that requires patience from both the clinician and the patient.

During the first few months, medication doses are typically tapered as the stimulation is optimized. This “washout” period can be challenging as the brain adapts to the new electrical environment, but it is necessary to find the most efficient stimulation parameters.

The referring neurologist often remains the primary point of contact for the patient’s overall neurological health. Understanding how to troubleshoot basic issues, such as identifying when a battery is low or recognizing signs of infection at the pulse generator site, enables the local care team to offer higher-level support. This integrated approach reduces the patient’s burden of traveling back and forth to the surgical center for minor concerns.

Ongoing education for the clinical staff on the latest advancements in directional leads and sensing technology (such as BrainSense) is also beneficial. These newer technologies enable more precise steering of the electrical field, which can help mitigate side effects such as speech or gait disturbances that were more common with older, omnidirectional electrodes.

Future Directions In Neuromodulation Referral Patterns

As our understanding of brain circuitry expands, the indications for DBS are likely to grow. We are already seeing increased interest in using DBS for refractory obsessive-compulsive disorder and certain types of epilepsy. For the movement disorder specialist, this means staying abreast of the evolving practice advisories from the American Academy of Neurology regarding new targets and patient populations.

The trend is clearly moving toward earlier intervention. Waiting for total disability is no longer the standard of care. By shifting the paradigm toward proactive neuromodulation, we can offer patients a significantly higher quality of life during their most active years. This requires a vigilant, informed, and courageous approach to patient advocacy from every member of the healthcare team.

If you are interested in exploring more about the practical applications of neurotechnology in clinical practice, I recommend reviewing clinical briefs on advanced programming techniques and patient selection for spinal cord stimulation.

Author Bio

Jameson Thorne is a clinical consultant and senior medical writer with over fifteen years of experience in the neurosurgical and neuromodulation space. He specializes in bridging the communication gap between specialized surgical centers and primary care networks to improve patient access to advanced therapies.

References

American Academy of Neurology. (2020). Guideline for Treatment of Early Parkinson’s Disease. https://www.aan.com/PressRoom/Home/PressRelease/4936  

Patricia Krause MD, Philipp Mahlknecht MD, PhD, et al (2025). Long-Term Outcomes on Pallidal Neurostimulation for Dystonia: A Controlled, Prospective 10-Year Follow-Up. https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.30130

Santos-García, T. de Deus Fonticoba, E. Suárez Castro, A. Aneiros Díaz, D. McAfee, (2020) 5-2-1 Criteria: A Simple Screening Tool for Identifying Advanced PD Patients Who Need an Optimization of Parkinson’s Treatment. https://onlinelibrary.wiley.com/doi/10.1155/2020/7537924

Please also review AIHCP’s Case Management Certification program and CE courses see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification